- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Pfizer's Lipitor revenue worldwide 2003-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Pfizer's Lipitor revenue worldwide 2003-2018
Worldwide revenue of Pfizer's Lipitor from 2003 to 2018 (in million U.S. dollars)
During 2018, Pfizer’s Lipitor generated nearly 2.1 billion U.S. dollars of revenue. This was the second year in a row with a reported increase after the record-low in 2016, with revenues of 1.76 billion dollars. For around a decade cholesterol-lowering drug Lipitor was one of the company’s top blockbusters, with record-high revenues of approximately 13 billion U.S. dollars in 2006. In the year of patent loss – 2011 – Lipitor still generated roughly 10 billion dollars, before a heavy drop down to four billion dollars in 2012.
Pharmaceutical company Pfizer
Drug manufacturer Pfizer is headquartered in Midtown Manhattan, New York City. At this moment, it is the world’s leading pharmaceutical company based on pharmaceutical sales of prescribed and over-the-counter drugs. Today, the company is focused on human medicine, divided into two major segments - Innovative Health and Essential Health. However, until 2013 the company also had a notable animal health division which was spun-off and today is known as Zoetis.
Facts about Lipitor/atorvastatin
Lipitor was approved by the FDA (Food and Drug Administration) in 1996 for medical use. Since its patent protection expired in 2011, it is now also sold under its generic name atorvastatin. Today, atorvastatin is one of the most prescribed drugs in the United States. The drug is primarily used as prevention for people with a high risk for developing cardiovascular diseases and as a treatment for abnormal lipid levels (dyslipidemia). Generic versions of Lipitor lead to annual savings in drug spending of around 16 billion U.S. dollars.
Worldwide revenue of Pfizer's Lipitor from 2003 to 2018 (in million U.S. dollars)
| Revenue in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Revenue in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
During 2018, Pfizer’s Lipitor generated nearly 2.1 billion U.S. dollars of revenue. This was the second year in a row with a reported increase after the record-low in 2016, with revenues of 1.76 billion dollars. For around a decade cholesterol-lowering drug Lipitor was one of the company’s top blockbusters, with record-high revenues of approximately 13 billion U.S. dollars in 2006. In the year of patent loss – 2011 – Lipitor still generated roughly 10 billion dollars, before a heavy drop down to four billion dollars in 2012.
Pharmaceutical company Pfizer
Drug manufacturer Pfizer is headquartered in Midtown Manhattan, New York City. At this moment, it is the world’s leading pharmaceutical company based on pharmaceutical sales of prescribed and over-the-counter drugs. Today, the company is focused on human medicine, divided into two major segments - Innovative Health and Essential Health. However, until 2013 the company also had a notable animal health division which was spun-off and today is known as Zoetis.
Facts about Lipitor/atorvastatin
Lipitor was approved by the FDA (Food and Drug Administration) in 1996 for medical use. Since its patent protection expired in 2011, it is now also sold under its generic name atorvastatin. Today, atorvastatin is one of the most prescribed drugs in the United States. The drug is primarily used as prevention for people with a high risk for developing cardiovascular diseases and as a treatment for abnormal lipid levels (dyslipidemia). Generic versions of Lipitor lead to annual savings in drug spending of around 16 billion U.S. dollars.
Show morePharmaceutical company Pfizer
Drug manufacturer Pfizer is headquartered in Midtown Manhattan, New York City. At this moment, it is the world’s leading pharmaceutical company based on pharmaceutical sales of prescribed and over-the-counter drugs. Today, the company is focused on human medicine, divided into two major segments - Innovative Health and Essential Health. However, until 2013 the company also had a notable animal health division which was spun-off and today is known as Zoetis.
Facts about Lipitor/atorvastatin
Lipitor was approved by the FDA (Food and Drug Administration) in 1996 for medical use. Since its patent protection expired in 2011, it is now also sold under its generic name atorvastatin. Today, atorvastatin is one of the most prescribed drugs in the United States. The drug is primarily used as prevention for people with a high risk for developing cardiovascular diseases and as a treatment for abnormal lipid levels (dyslipidemia). Generic versions of Lipitor lead to annual savings in drug spending of around 16 billion U.S. dollars.
- Show sources information
- Show publisher information
- Release date
- February 2019
- Region
- Worldwide
- Survey time period
- 2003 to 2018
- Supplementary notes
- This statistic was assembled from several of Pfizer's annual and financial reports.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- February 2019
More information
- Region
- Worldwide
- Survey time period
- 2003 to 2018
- Supplementary notes
- This statistic was assembled from several of Pfizer's annual and financial reports.
- Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Pfizer
- 54 page/s
- English
- pptx
- Detailed references
Everything On "Pfizer" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Pfizer"
- Global positioning
The most important statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)2018 list of global top 10 biotech and pharmaceutical companies based on net income
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2018
- Brand value of the world's most valuable pharmaceutical brands as of 2019 (in million U.S. dollars)World's most valuable pharmaceutical brands 2019 by brand value
- Largest pharmaceutical industry mergers and acquisitions ever worldwide until early 2019 (in billion U.S. dollars)Largest M&A pharmaceutical deals ever as of 2019
- Top 10 pharmaceutical companies worldwide by number of originated drugs in 2019*Top pharma companies worldwide by number of originated drugs 2019
- Revenues
The most important statistics
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)Pfizer's total revenue 2006-2018
- Pfizer's revenue from 1st quarter 2010 to 4th quarter 2018 (in million U.S. dollars)Pfizer's quarterly revenue 2010-2018
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*Pfizer's revenue by segment 2014-2018
- Pfizer's revenues in global submarkets from 2010 to 2018 (in million U.S. dollars)Pfizer's revenues in global submarkets 2010-2018
- Pfizer's revenues in the U.S. and abroad from 2009 to 2018 (in million U.S. dollars)Pfizer's revenues in the U.S. and abroad 2009-2018
- Selected top products
The most important statistics
- Pfizer's top 10 products based on revenue in 2018 (in million U.S. dollars)Pfizer's top products based on revenue 2018
- Worldwide revenue of Pfizer's Lipitor from 2003 to 2018 (in million U.S. dollars)Pfizer's Lipitor revenue worldwide 2003-2018
- Worldwide revenue of Pfizer's Viagra from 2003 to 2018 (in million U.S. dollars)Pfizer's Viagra revenue worldwide 2003-2018
- Expenditures/payments
The most important statistics
- Pfizer's expenditure on research and development from 2006 to 2018 (in million U.S. dollars)Pfizer's expenditure on research and development 2006-2018
- Pfizer's ad spending from 2008 to 2018 (in billion U.S. dollars) Pfizer's ad spending 2008-2018
- Cash dividends paid by Pfizer from 2006 to 2018 (in million U.S. dollars)Pfizer - cash dividends paid 2006-2018
- Other key data
The most important statistics
- Pfizer's net income from 2006 to 2018 (in million U.S. dollars)Pfizer's net income 2006-2018
- Pfizer's total assets from 2006 to 2018 (in million U.S. dollars)Pfizer's total assets 2006-2018
- Net earnings per Pfizer share from 2008 to 2018 (in U.S. dollars)*Net earnings per Pfizer share 2008-2018
- Pfizer's long-term debt from 2008 to 2018 (in million U.S. dollars)Pfizer's long-term debt 2008-2018
- Pfizer's number of employees from 2006 to 2018Pfizer's total number of employees 2006-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Pfizer's Animal Health revenue worldwide 2003-2012
- Pfizer SL: number of employees in Spain 2010-2017
- Sales value of Pfizer SL in Spain 2012-2015
- Pfizer: ad spend in the U.S. 2009-2017
- Pfizer's ad spend for Viagra in the U.S. in 2011 and 2013
- Pfizer: advertising spending worldwide 2015-2016
- Pfizer - ad spend in the U.S. 2014, by medium
- Forecast of EBITDA of Pfizer 2017-2018
- Drug price changes in the U.S. by product group until end-2019
- Insulin-replacement medications - revenues 2010
- Leading pharmaceutical companies in Finland 2016
- Lisinopril out-of-pocket cost U.S. 2004-2016
- Amlodipine besylate out of pocket price U.S. 2004-2016
- U.S. hospitals with select levels of medication price markups 2017
- Number of users of benzodiazepines in Denmark 2012-2017
- Health and social care employees in the Czech Republic 2000-2015
- Current health spending in South Korea 2008-2017
- Support for legalizing medical marijuana in Singapore 2018
- Unit shipments of enterprise client devices worldwide 2013-2015, by vendor
Statistics on "Pfizer"
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)
- Brand value of the world's most valuable pharmaceutical brands as of 2019 (in million U.S. dollars)
- Largest pharmaceutical industry mergers and acquisitions ever worldwide until early 2019 (in billion U.S. dollars)
- Top 10 pharmaceutical companies worldwide by number of originated drugs in 2019*
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)
- Pfizer's revenue from 1st quarter 2010 to 4th quarter 2018 (in million U.S. dollars)
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*
- Pfizer's revenues in global submarkets from 2010 to 2018 (in million U.S. dollars)
- Pfizer's revenues in the U.S. and abroad from 2009 to 2018 (in million U.S. dollars)
- Pfizer's top 10 products based on revenue in 2018 (in million U.S. dollars)
- Worldwide revenue of Pfizer's Lipitor from 2003 to 2018 (in million U.S. dollars)
- Worldwide revenue of Pfizer's Viagra from 2003 to 2018 (in million U.S. dollars)
- Pfizer's expenditure on research and development from 2006 to 2018 (in million U.S. dollars)
- Pfizer's ad spending from 2008 to 2018 (in billion U.S. dollars)
- Cash dividends paid by Pfizer from 2006 to 2018 (in million U.S. dollars)
- Pfizer's net income from 2006 to 2018 (in million U.S. dollars)
- Pfizer's total assets from 2006 to 2018 (in million U.S. dollars)
- Net earnings per Pfizer share from 2008 to 2018 (in U.S. dollars)*
- Pfizer's long-term debt from 2008 to 2018 (in million U.S. dollars)
- Pfizer's number of employees from 2006 to 2018
- Pfizer's Animal Health revenue worldwide from 2003 to 2012 (in million U.S. dollars)*
- Number of Pfizer SL employees in Spain from 2010 to 2017
- Annual sales value of Pfizer SL in Spain from 2012 to 2015 (in million euros)
- Pfizer's advertising spending in the United States from 2009 to 2017 (in billion U.S. dollars)
- Pfizer's advertising spending for Viagra in the United States from 2011 to 2013 (in million U.S. dollars)
- Pfizer's advertising spending worldwide from 2015 to 2016 (in billion U.S. dollars)
- Pfizer's direct-to-consumer (DTC) advertising spending in the United States in 2014, by medium (in million U.S. dollars)
- Forecast of EBITDA of Pfizer Inc in 2017 and 2018 (in million U.S. dollars)
- Projected 18-month drug price changes in the U.S. until end-2019, by product group
- Revenues from leading insulin-replacement medications in 2010 (in billion euros)
- Leading pharmaceutical companies in Finland in 2016, by total sales (in million euros)
- Lisinopril out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*
- Amlodipine besylate out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*
- Percentage of hospitals with select levels of markup for medicines as of 2017
- Number of users of benzodiazepines in Denmark from 2012 to 2017 (per 1,000 inhabitants)
- Number of employees in the health and social care industry in the Czech Republic from 2000 to 2015 (in 1,000)
- Current health expenditure in South Korea from 2008 to 2017 (in trillion South Korean won)
- Share of respondents who support legalizing marijuana for medical use in Singapore as of October 2018
- Enterprise client device unit shipments worldwide from the 1st quarter 2013 to the 3rd quarter 2015 (in 1,000s)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.